anti-OX40 antibody (Celltech)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-OX40 antibody (Celltech)

Drug Alias NameOX40 antibody-cytotoxic drug conjugates (Celltech)OX40 therapeutics (Celltech)OX40-positive cell ablating antibody (UCB Celltech)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionT lymphocytes inhibitorsTumor necrosis factor receptor superfamily member 4 modulators

TargetsTumor necrosis factor receptor superfamily member 4

Therapy Area/IndicationsAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUcb Celltech

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUcb Celltech

Active IndicationsN/A

Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A